51
Participants
Start Date
June 13, 2022
Primary Completion Date
November 30, 2022
Study Completion Date
November 30, 2022
TRPA1-inhibitor
Pharmacological inhibition of TRPA1 during intradermal injection of hot synthetic interstitial fluid
TRPV1-inhibitor
Pharmacological inhibition of TRPV1 during intradermal injection of hot synthetic interstitial fluid
TRPM3-inhibitor
Pharmacological inhibition of TRPM3 during intradermal injection of hot synthetic interstitial fluid
Placebo
No pharmacological intervention
Chloride-channel inhibitor
Pharmacological inhibition of a chloride channel during intradermal injection of hot synthetic interstitial fluid
Medical University of Vienna, Vienna
Medical University of Vienna
OTHER